ReviewCurrent protein & peptide science2024

Emicizumab as a Promising Form of Therapy for Type A Hemophilia - A Review of Current Knowledge from Clinical Trials.

Katarzyna Grabowska et al.PubMed ↗Publisher ↗

No numbers read from the abstract.